tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Inotiv gains preliminary approval for derivative settlement agreement

Story Highlights
  • Inotiv won preliminary court approval for a derivative settlement tied to its Envigo merger.
  • The proposed deal would add governance measures and channel insurance funds to resolve related claims.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Inotiv gains preliminary approval for derivative settlement agreement

Claim 70% Off TipRanks Premium

The latest announcement is out from Inotiv ( (NOTV) ).

On January 7, 2026, a federal court in the Northern District of Indiana granted preliminary approval to a proposed settlement of consolidated federal and state stockholder derivative actions arising from Inotiv’s 2021 merger with Envigo RMS LLC and related disclosures, with a final approval hearing scheduled for March 18, 2026. Subject to final court approval, the settlement would fully resolve all derivative claims against individual defendants and Inotiv as a nominal defendant, require the company to implement and maintain specified corporate governance measures, and provide a $2.49 million insurance-funded payment for the benefit of the company to be used toward payments to members of a related securities class action, while any attorneys’ fees awarded to plaintiffs’ counsel, up to $2.25 million, are also expected to be paid entirely by insurance and the stipulation includes no admission of liability.

The most recent analyst rating on (NOTV) stock is a Hold with a $0.59 price target. To see the full list of analyst forecasts on Inotiv stock, see the NOTV Stock Forecast page.

Spark’s Take on NOTV Stock

According to Spark, TipRanks’ AI Analyst, NOTV is a Neutral.

The score is held down primarily by weak financial performance (losses, leverage, and weak cash flow) and bearish technicals (below key moving averages with negative MACD). A more constructive earnings-call outlook (DSA growth, improved cash from operations, higher adjusted EBITDA) provides partial offset, while the Nasdaq bid-compliance notice adds incremental risk.

To see Spark’s full report on NOTV stock, click here.

More about Inotiv

Inotiv, Inc. operates in the life sciences sector, providing nonclinical and analytical drug discovery and development services, and expanded its operations through a November 5, 2021 merger with Envigo RMS LLC, a global provider of research models and services with facilities in the United States and abroad.

Average Trading Volume: 822,835

Technical Sentiment Signal: Sell

Current Market Cap: $20.9M

For detailed information about NOTV stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1